PVS23: Corcym Perceval Sutureless Heart Valve Aortic, Medium

Sign in to add this product to your favorites!
| Price: | $2,999.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 1 box of 1 |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 5 hours 12 minutes and choose overnight shipping at checkout. |
Additional Details
Corcym Perceval Sutureless Heart Valve Aortic
Corcym Perceval Sutureless Heart Valve Aortic, Medium
Product Code: PVS23
- Size: Medium
Sterilization
- Device Packaged as Sterile: Yes
- Requires Sterilization Prior to Use: No
- Single-Use
- Disposable
Additional Details
- Company Name: Corocym SRL
- FDA Product Code: LWR
- FDA Product Code Name: Heart-Valve, Non-Allograft Tissue
- GMDN Term Code: 60242
- GMDN Term Name: Aortic open-surgery heart valve bioprosthesis
- GMDN Term Definition: A xenograft (e.g., porcine or bovine heart valve) intended to be implanted in a patient during open heart surgery to repair or replace a dysfunctional aortic heart valve. It is processed to render the tissue in the valve non-viable; it may be tissue only, or tissue attached to a metal or synthetic polymer framework. The device is typically used to treat acquired or congenital valvular disease.
AccessGUDID Info
- FDA Product Code: LWR
- FDA Product Code Name: Heart-Valve, Non-Allograft Tissue
- GMDN Term Code: 60242
- GMDN Term Name: Aortic open-surgery heart valve bioprosthesis
- GMDN Term Description: A xenograft (e.g., porcine or bovine heart valve) intended to be implanted in a patient during open heart surgery to repair or replace a dysfunctional aortic heart valve. It is processed to render the tissue in the valve non-viable; it may be tissue only, or tissue attached to a metal or synthetic polymer framework. The device is typically used to treat acquired or congenital valvular disease.
Manufacturer
Corcym is a global medical device company dedicated to structural heart therapies, with a focus on cardiac surgery. Formerly part of LivaNova, Corcym became an independent company to concentrate exclusively on surgical heart valve technologies. Its portfolio includes tissue valve solutions such as the Perceval sutureless aortic valve and the CROWN PRT bioprosthesis, designed to streamline implantation and improve durability. Corcym also offers mechanical valves, annuloplasty rings, and accessories that support both conventional and minimally invasive cardiac procedures. With a commitment to advancing outcomes in structural heart disease, Corcym partners with cardiac surgeons worldwide to deliver next-generation valve therapies.
IN-DATE